Incyte Corporation (INCY) — Analyst outlook / Analyst consensus target is. Based on 44 analyst ratings, the consensus is bullish — 24 Buy, 18 Hold, 2 Sell.
The consensus price target is $108.90 (low: $84.00, high: $135.00), representing an upside of 11.5% from the current price $97.69.
Analysts estimate Earnings Per Share (EPS) of $1.28 and revenue of $4.20B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.16 vs est $1.28 (missed -87.5%). 2025: actual $6.59 vs est $6.75 (missed -2.3%). Analyst accuracy: 0%.
INCY Stock — 12-Month Price Forecast
$108.90
▲ +11.48% Upside
Average Price Target
Based on 44 Wall Street analysts offering 12-month price targets for Incyte Corporation, the average price target is $108.90, with a high forecast of $135.00, and a low forecast of $84.00.
The average price target represents a +11.48% change from the last price of $97.69.
Highest Price Target
$135.00
Average Price Target
$108.90
Lowest Price Target
$84.00
INCY Analyst Ratings
Buy
Based on 44 analysts giving stock ratings to Incyte Corporation in the past 3 months
EPS Estimates — INCY
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.16
vs Est $1.28
▼ 697.3% off
2025
Actual $6.59
vs Est $6.75
▼ 2.4% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — INCY
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $4.241B
vs Est $4.204B
▲ 0.9% off
2025
Actual $5.141B
vs Est $4.980B
▲ 3.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
